Opendata, web and dolomites

SIGUEMED SIGNED

The first affordable and easy-to-use IoT system that tracks pill intake with printed circuits technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SIGUEMED project word cloud

Explore the words cloud of the SIGUEMED project. It provides you a very rough idea of what is the project "SIGUEMED" about.

ehealth    eu28    iot    medication    records    treatment    siguemed    00    convenient    solutions    clients    contact    digital    circuits    pills    immigrants    extra    hospitalisations    personalized    sent    reports    first    pharmacies    printed    350    massive    platform    heavy    patients    sw    authorized    create    200    chronic    cascade    intake    additional    demands    distributors    connected    none    solution    provides    premature    shape    services    commercialization    foil    commercialize    pharmacists    unsolved    bridge    medical    monthly    correct    world    pack    attempt    citizens    monitoring    market    associate    economic    time    125    smart    people    disruptive    reached    wearables    track    remind    countries    network    societal    medicated    deaths    base    place    caretaker    gap    sufficient    sale    relatives    dock    breach    bluetooth    combining    meet    adherence    poly    alerts    blister    roi    penetration    burden   

Project "SIGUEMED" data sheet

The following table provides information about the project.

Coordinator
INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL 

Organization address
address: AVENIDA DEL PAPA NEGRO 129 6F
city: MADRID
postcode: 28043
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL ES (MADRID) coordinator 50˙000.00

Map

 Project objective

SIGUEMED is provides the first cost-effective and convenient solution to an unsolved world-wide problem of massive economic and societal impact: the non-adherence to medication of chronic poly-medicated patients. Low medical adherence represents a heavy burden for the EU28 in terms of: - Cost due to extra medical treatment that needs to be given and to additional hospitalisations: estimated at 125,000 M€/year. - Premature deaths that could be avoided with correct adherence to medication: over 200,00 citizens/year Currently there are several solutions that attempt to increase medication adherence, but none of them reaches a sufficient market penetration because they are not useful enough or do not fully meet user demands. To bridge that market gap, we have developed SIGUEMED. SIGUEMED is an IoT eHealth solution aimed at fostering and monitoring medical adherence in a disruptive way. By combining a smart personalized blister pack with printed circuits in its foil (key enabling technology), wearables connected via Bluetooth to the base dock and a SW platform, we are able to remind to the patients intake the time for the intake of pills, and to track if and when this intake has taken place. If there has been any breach in the intake, a cascade of alerts is sent to contact people (relatives, caretaker, pharmacists). Access to track records and monthly reports is also possible. SIGUEMED is especially user-friendly, even for digital immigrants. To commercialize SIGUEMED we will create a network of associated pharmacies, which will be our clients and will shape our network of authorized distributors. They will sale and provide SIGUEMED’s associate services to poly-medicated patients, which are the end-users. After five year of commercialization, we expect to have built a network of more than 10,000 pharmacies in 5 different EU countries and have reached more than 350,000 patients through them. The ROI of the project is of 3.80.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SIGUEMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SIGUEMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More  

Osto.Me (2020)

Ostomy Market Disruption: First Leak Proof Ostomy Appliance removing the need for Accessories in the Ostomy Market

Read More